Syntropharma Overview

  • Year Founded
  • 2005

Year Founded

  • Status
  • Out of Business

  • Employees
  • 5

Employees

  • Latest Deal Type
  • Bankr. Admin/​Reorg

Syntropharma General Information

Description

Developer of pharmaceutical products designed to treat Alzheimer's disease and depression. The company's products are used to treat neurological diseases, enabling healthcare providers to improve the lives of their patients and cure them.

Contact Information

Website
www.syntropharma.com
Formerly Known As
Nine Hill Street
Ownership Status
Out of Business
Financing Status
Formerly VC-backed
Corporate Office
  • Unit 3
  • Tweed Horizons Business Centre
  • Newtown Saint Boswells TD6 0SG
  • Scotland, United Kingdom
+44 01835
Primary Industry
Pharmaceuticals
Other Industries
Drug Discovery
Vertical(s)
Life Sciences
Corporate Office
  • Unit 3
  • Tweed Horizons Business Centre
  • Newtown Saint Boswells TD6 0SG
  • Scotland, United Kingdom
+44 01835

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Syntropharma Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
7. Bankruptcy: Admin/Reorg 05-Oct-2020 Completed Bankruptcy: Admin/Reorg
6. Equity Crowdfunding 16-Aug-2015 Completed Generating Revenue
5. Later Stage VC 17-Feb-2012 Completed Generating Revenue
4. Later Stage VC 01-Mar-2011 Completed Generating Revenue
3. Early Stage VC 18-Dec-2009 Completed Startup
2. Early Stage VC (Series B) 01-Aug-2008 $2.48M $4.39M Completed Startup
1. Early Stage VC 24-Nov-2006 $1.9M $1.9M Completed Startup
To view Syntropharma’s complete valuation and funding history, request access »

Syntropharma Cap Table

Stock # of Shares
Authorized		 Par Value Dividend Rate (%) Original
Issue Price		 Liquidation Liquidation
Pref. Multiple		 Conversion Price % Owned
Ordinary
Ordinary
Ordinary 11,920 $0.000157 $204.09 $204.09 $204.09 22.14%
To view Syntropharma’s complete cap table history, request access »

Syntropharma Patents

  • 4

    Total Documents Applications and Grants

  • Total Patents Families

  • Granted

  • 1

    Pending

  • Expiring in next 12 mo

Syntropharma Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
JP-2011513287-A Pharmaceutical composition Pending 28-Feb-2008
WO-2009106831-A2 Pharmaceutical composition Inactive 28-Feb-2008
EP-2259780-A2 Pharmaceutical composition comprising naltrexone Inactive 28-Feb-2008
WO-2009106831-A3 Pharmaceutical composition comprising naltrexone Inactive 28-Feb-2008 A61K31/485

Syntropharma Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Ready to get started?

Request a free trial

Syntropharma FAQs

  • When was Syntropharma founded?

    Syntropharma was founded in 2005.

  • Where is Syntropharma headquartered?

    Syntropharma is headquartered in Newtown Saint Boswells, United Kingdom.

  • What is the size of Syntropharma?

    Syntropharma has 5 total employees.

  • What industry is Syntropharma in?

    Syntropharma’s primary industry is Pharmaceuticals.

  • Is Syntropharma a private or public company?

    Syntropharma is a Private company.

  • What is Syntropharma’s current revenue?

    The current revenue for Syntropharma is .

  • How much funding has Syntropharma raised over time?

    Syntropharma has raised $6.66M.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process